<img src="//bat.bing.com/action/0?ti=5025073&amp;Ver=2" height="0" width="0" style="display:none; visibility: hidden;">

CEO Roundtable Discussion: Fundraising and Pitching Strategy (Members Only)

Speaker

Event Details

This month our guest speaker is Garrett Ruhland, CEO and co-founder of Biomarker.io. Join us on July 24 to discuss fundraising and pitching strategies. Expect a quick review of the basics and prerequisites early-stage startups must have in preparation to seek capital. Then, we’ll dive into a discussion about methods for creating your investor list, preparing your pitch, and constructing a timeline.
 
Garrett is an accomplished startup founder with experience in biotechnology, digital health, and software development. He will leverage his expertise in the translation of highly technical concepts into commercially viable solutions to present practical and effective strategies perfect for companies at any stage of the fundraising process.
 
Some of the topics we will cover:
  • Fundraising strategies for early-stage startups
  • Defining different stages in the fundraising process
  • Learning the lingo + reading between the lines
Agenda
11:45 am - 12:00 pm | Lunch Served
12:00 pm - 12:10 pm | Quick Intros
12:10 pm - 12:20 pm | Expert Speaker
12:20 pm - 12:50 pm | Q+A
12:50 pm - 01:00 pm | Wrap up
 

Seats fill up quickly! Registration Required.

 

What is the RocketSpace CEO Roundtable Discussion?

The CEO Roundtable Discussion is held each month during lunch, provided by RocketSpace. The goal behind this monthly meeting is to give members the opportunity to sit down with their peers to exchange ideas, discuss common challenges and, of course, network. The CEO Roundtable Discussions are only open to current RocketSpace members who are founders or CEOs.

 

About the Speaker

Garrett is an accomplished startup founder with experience in biotechnology, digital health, and software development. Garrett is an expert in translating clinical research into commercially viable solutions. His strengths reside in his ability to fluently communicate between clinical, engineering & management teams to facilitate optimal collaboration and project execution. He has prior experience in operational roles at truBrain as Chief of R&D, management roles as Chief Medical Officer at Koroit Capital and CEO at Biomarker I/O.
RSVP for this Event

Upcoming Events